secwatch.observer — SEC 8-K summary
======================================

Issuer:     SkinHealth Systems Inc. (SKIN)
CIK:        0001818093
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001628280-25-023780
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeautyHealth Q1 revenue $69.6M (-14% YoY); adjusted EBITDA $7.3M vs $0.4M
-------------------------------------------------------------------------

- Net sales $69.6M down from $81.4M; delivery systems $20.2M (-43.6%), consumables $49.4M (+8.3%).
- Net loss $10.1M vs loss $0.7M; adjusted EBITDA $7.3M (10.4% margin) vs $0.4M.
- Gross margin improved to 69.8% from 59.4%; delivery systems sold 862, install base 35,014 (+7.6%).
- CEO cites exceeding revenue and adjusted EBITDA guidance; relocating production to U.S. to mitigate tariff risk.
- Transitioning China operations to a distributor model; product launches and brand initiatives planned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818093/000162828025023780/0001628280-25-023780-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818093/000162828025023780/skin-20250508.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-023780

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer